Jason Schwartz is an assistant professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jason Schwartz . (2020). Interview with Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005882&aid=10.1056%2FNEJMp2029479&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

New model can predict how bacteria develop antibiotic resistance

ScienceDaily recently reported on a study led by...

El estilo de vida bacteriano altera la evolución de la resistencia a los antibióticos.

Investigadores de la Facultad de Medicina de la...

Hospital superbug traced to remote island beach

According to SciDev.Net, researchers have...

By changing their shape, some bacteria can grow more resilient to antibiotics

ScienceDaily recently reported on new research...

Superbug MRSA arose in hedgehogs long before clinical use of antibiotics.

Superbug MRSA arose in hedgehogs long before...

A novel protein therapy for efficient skin wound healing

A group of researchers at A*STAR’s (Agency for...

Life expectancy to break 90 barrier by 2030

A study by Imperial College London and the World...

La resistencia a los antibióticos puede extenderse en ausencia de medicamentos.

Medical News Today informó recientemente sobre...

Beautyberry leaf extract restores drug’s power to fight ‘superbug’

According to an article recently shared by...

COVID-19 cited in significant increase in healthcare-associated infections in 2020

According to ScienceDaily, a CDC analysis of...

Distribuidor exclusivo.

0